spacer
spacer

PDBsum entry 1b10

Go to PDB code: 
protein links
Prion protein PDB id
1b10

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
104 a.a. *
* Residue conservation analysis
PDB id:
1b10
Name: Prion protein
Title: Solution nmr structure of recombinant syrian hamster prion protein rprp(90-231) , 25 structures
Structure: Protein (prion protein). Chain: a. Fragment: 90 - 231. Synonym: sha rprp90-231. Engineered: yes
Source: Mesocricetus auratus. Golden hamster. Organism_taxid: 10036. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_atcc_number: 55244. Other_details: genentech derived vector system
NMR struc: 25 models
Authors: T.L.James,H.Liu,N.B.Ulyanov,S.Farr-Jones
Key ref:
T.L.James et al. (1997). Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A, 94, 10086-10091. PubMed id: 9294167 DOI: 10.1073/pnas.94.19.10086
Date:
25-Nov-98     Release date:   02-Dec-98    
Supersedes: 2prp
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P04273  (PRIO_MESAU) -  Major prion protein from Mesocricetus auratus
Seq:
Struc:
254 a.a.
104 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 

 
DOI no: 10.1073/pnas.94.19.10086 Proc Natl Acad Sci U S A 94:10086-10091 (1997)
PubMed id: 9294167  
 
 
Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform.
T.L.James, H.Liu, N.B.Ulyanov, S.Farr-Jones, H.Zhang, D.G.Donne, K.Kaneko, D.Groth, I.Mehlhorn, S.B.Prusiner, F.E.Cohen.
 
  ABSTRACT  
 
The scrapie prion protein (PrPSc) is the major, and possibly the only, component of the infectious prion; it is generated from the cellular isoform (PrPC) by a conformational change. N-terminal truncation of PrPSc by limited proteolysis produces a protein of approximately 142 residues designated PrP 27-30, which retains infectivity. A recombinant protein (rPrP) corresponding to Syrian hamster PrP 27-30 was expressed in Escherichia coli and purified. After refolding rPrP into an alpha-helical form resembling PrPC, the structure was solved by multidimensional heteronuclear NMR, revealing many structural features of rPrP that were not found in two shorter PrP fragments studied previously. Extensive side-chain interactions for residues 113-125 characterize a hydrophobic cluster, which packs against an irregular beta-sheet, whereas residues 90-112 exhibit little defined structure. Although identifiable secondary structure is largely lacking in the N terminus of rPrP, paradoxically this N terminus increases the amount of secondary structure in the remainder of rPrP. The surface of a long helix (residues 200-227) and a structured loop (residues 165-171) form a discontinuous epitope for binding of a protein that facilitates PrPSc formation. Polymorphic residues within this epitope seem to modulate susceptibility of sheep and humans to prion disease. Conformational heterogeneity of rPrP at the N terminus may be key to the transformation of PrPC into PrPSc, whereas the discontinuous epitope near the C terminus controls this transition.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. Secondary structure diagram for rPrP. NOE connectivities are denoted by lines, where the thickness qualitatively represents the relative intensity (weak, medium, or strong) of the NOE crosspeaks, and i designates the residue number for rPrP. d[ N](i, i+3) denotes an NOE between the -proton of residue i and the amide^ proton of residue i+3. The long-range NOE line indicates by height the relative number of NOE crosspeaks between residues i i + 4. In the consensus chemical shift index (59), contiguous up bars designate -helix and down bars designate -strand. Regions of secondary structure are depicted by helices for -helices and^ broad arrows for -strands. Hydrogen exchange was calculated from the intensity of proton NOE crosspeak between the amide and water: open circles for slow, filled for fast, and half-filled circles for medium exchange rate. No circle indicates spectral overlap or proline. The secondary structure diagram was created using the program VINCE (60).
Figure 2.
Fig. 2. NMR structure of SHa rPrP(90-231). (A) Comparison of the 15 best-scoring structures of rPrP shown with a best-fit superposition of backbone atoms for residues 113-227 (stereoview). In all figures except C, the color scheme is: disulfide between Cys179 and Cys214, yellow; sites of glycosidation in PrPC, i.e., Asn181 and Asn197, gold; hydrophobic cluster composed of residues 113-126, red; helices, pink; loops, gray; residues 129-134, green, encompassing strand S1 and residues 159-165, blue, encompassing strand S2; the arrows span residues 129-131 and 161-163, as these show a^ closer resemblance to -sheet. The structures were generated with the program DIANA (30), followed by energy minimization with AMBER 4.1 (31). Structure generation parameters are as follows: 2,401 distance restraints (intraresidue, 858; sequential (i i +1), 753; (i i +2), 195; (i i +3), 233; (i i +4), 109; and (i i + 5), 253 for amino acid i); hydrogen bond restraints, 44; distance restraint violations >0.5 Å per structure, 30; AMBER energy, 1,443 ± 111 kcal/mol. Precision of structures: atomic^ rms deviation for all backbone heavy atoms of residues 128-227, <1.9 Å. The distance restraint violations and precision in some^ molecular moities reflect the conformational heterogeneity of^ rPrP. (B) Residues 113-132 illustrating (stereoview) in one representative^ structure the interaction of the hydrophobic cluster, with van der Waals rendering of atoms in residues 113-127, with the first -strand. (C) Van der Waals surface of rPrP turned approximately 180° from A, illustrating the interaction of helix A with helix C. Helices A, B, and C are colored magenta, cyan, and gold, respectively. (D) Stereoview, using RIBBONJR, illustrating the proximity of^ helix C to the 165-171 loop and the end of helix B, where residues Gln168 and Gln172 are depicted with a low-density van der Waals rendering and helix C residues Thr215 and Gln219 are depicted with a high-density van der Waals rendering. (E) Stereoview, highlighting in white the residues corresponding to point mutations that lead to human prion diseases. Illustrations were generated with MIDASPLUS. (F) Portion of the three-dimensional 13C-NOESY spectrum corresponding to 13C planes of the unresolved Val166 methyl resonances and the Ser222 resonances (a-d) and the 15N plane showing the Tyr225 amide interaction with Val166 (e). The diagonal peaks and mirrored crosspeaks for each 1H-1H connectivity are shown. The solid lines connecting peaks designate^ NOE connectivities.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20337594 C.A.Tabrett, C.F.Harrison, B.Schmidt, S.A.Bellingham, T.Hardy, Y.H.Sanejouand, A.F.Hill, and P.J.Hogg (2010).
Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function.
  Biochem J, 428, 169-182.  
20564047 D.Wu, W.Zhang, Q.Luo, K.Luo, L.Huang, W.Wang, T.Huang, R.Chen, Y.Lin, D.Pang, and G.Xiao (2010).
Copper (II) promotes the formation of soluble neurotoxic PrP oligomers in acidic environment.
  J Cell Biochem, 111, 627-633.  
20067571 N.Daude, V.Ng, J.C.Watts, S.Genovesi, J.P.Glaves, S.Wohlgemuth, G.Schmitt-Ulms, H.Young, J.McLaurin, P.E.Fraser, and D.Westaway (2010).
Wild-type Shadoo proteins convert to amyloid-like forms under native conditions.
  J Neurochem, 113, 92.  
20409471 P.J.Robinson, and T.J.Pinheiro (2010).
Phospholipid composition of membranes directs prions down alternative aggregation pathways.
  Biophys J, 98, 1520-1528.  
20454997 S.Lisa, M.Meli, G.Cabello, R.Gabizon, G.Colombo, and M.Gasset (2010).
The structural intolerance of the PrP alpha-fold for polar substitution of the helix-3 methionines.
  Cell Mol Life Sci, 67, 2825-2838.  
20653509 V.N.Uversky (2010).
Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept.
  Expert Rev Proteomics, 7, 543-564.  
20949107 Y.Wen, J.Li, M.Xiong, Y.Peng, W.Yao, J.Hong, and D.Lin (2010).
Solution structure and dynamics of the I214V mutant of the rabbit prion protein.
  PLoS One, 5, e13273.
PDB code: 2jom
19173221 D.B.O'Sullivan, C.E.Jones, S.R.Abdelraheim, M.W.Brazier, H.Toms, D.R.Brown, and J.H.Viles (2009).
Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.
  Protein Sci, 18, 410-423.  
19255752 D.C.Jenkins, D.S.Pearson, A.Harvey, I.D.Sylvester, M.A.Geeves, and T.J.Pinheiro (2009).
Rapid folding of the prion protein captured by pressure-jump.
  Eur Biophys J, 38, 625-635.  
19381364 E.Gralka, D.Valensin, K.Gajda, D.Bacco, L.Szyrwiel, M.Remelli, G.Valensin, W.Kamasz, W.Baranska-Rybak, and H.Kozłowski (2009).
Copper(II) coordination outside the tandem repeat region of an unstructured domain of chicken prion protein.
  Mol Biosyst, 5, 497-510.  
19649330 J.C.Geoghegan, M.B.Miller, A.H.Kwak, B.T.Harris, and S.Supattapone (2009).
Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor.
  PLoS Pathog, 5, e1000535.  
19533034 J.Y.Shin, J.I.Shin, J.S.Kim, Y.S.Yang, Y.K.Shin, K.K.Kim, S.Lee, and D.H.Kweon (2009).
Disulfide bond as a structural determinant of prion protein membrane insertion.
  Mol Cells, 27, 673-680.  
19193264 K.D.Meade-White, K.D.Barbian, B.Race, C.Favara, D.Gardner, L.Taubner, S.Porcella, and R.Race (2009).
Characteristics of 263K scrapie agent in multiple hamster species.
  Emerg Infect Dis, 15, 207-215.  
19226372 M.L.DeMarco, and V.Daggett (2009).
Characterization of cell-surface prion protein relative to its recombinant analogue: insights from molecular dynamics simulations of diglycosylated, membrane-bound human prion protein.
  J Neurochem, 109, 60-73.  
19391622 S.H.Bae, H.J.Dyson, and P.E.Wright (2009).
Prediction of the rotational tumbling time for proteins with disordered segments.
  J Am Chem Soc, 131, 6814-6821.  
19348007 S.Hornemann, B.Christen, C.von Schroetter, D.R.Pérez, and K.Wüthrich (2009).
Prion protein library of recombinant constructs for structural biology.
  FEBS J, 276, 2359-2367.  
19666719 T.Mashima, A.Matsugami, F.Nishikawa, S.Nishikawa, and M.Katahira (2009).
Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein.
  Nucleic Acids Res, 37, 6249-6258.
PDB code: 2rqj
18023239 A.Verma, S.Sharma, N.K.Ganguly, S.Majumdar, P.Guptasarma, and M.Luthra-Guptasarma (2008).
Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
  Int J Biochem Cell Biol, 40, 663-676.  
18279390 D.C.Jenkins, I.D.Sylvester, and T.J.Pinheiro (2008).
The elusive intermediate on the folding pathway of the prion protein.
  FEBS J, 275, 1323-1335.  
18669653 K.Elfrink, J.Ollesch, J.Stöhr, D.Willbold, D.Riesner, and K.Gerwert (2008).
Structural changes of membrane-anchored native PrP(C).
  Proc Natl Acad Sci U S A, 105, 10815-10819.  
  19158507 K.Sasaki, J.Gaikwad, S.Hashiguchi, T.Kubota, K.Sugimura, W.Kremer, H.R.Kalbitzer, and K.Akasaka (2008).
Reversible monomer-oligomer transition in human prion protein.
  Prion, 2, 118-122.  
18528629 L.F.Agnati, E.Baldelli, N.Andreoli, A.S.Woods, V.Vellani, D.Marcellino, D.Guidolin, and K.Fuxe (2008).
On the key role played by altered protein conformation in Parkinson's disease.
  J Neural Transm, 115, 1285-1299.  
18789949 V.G.Ostapchenko, N.Makarava, R.Savtchenko, and I.V.Baskakov (2008).
The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP.
  J Mol Biol, 383, 1210-1224.  
18573080 V.N.Uversky, C.J.Oldfield, and A.K.Dunker (2008).
Intrinsically disordered proteins in human diseases: introducing the D2 concept.
  Annu Rev Biophys, 37, 215-246.  
18537543 V.N.Uversky (2008).
Amyloidogenesis of natively unfolded proteins.
  Curr Alzheimer Res, 5, 260-287.  
  19164911 A.Pastore, and A.Zagari (2007).
A structural overview of the vertebrate prion proteins.
  Prion, 1, 185-197.  
17397138 C.W.Lennon, H.D.Cox, S.P.Hennelly, S.J.Chelmo, and M.A.McGuirl (2007).
Probing structural differences in prion protein isoforms by tyrosine nitration.
  Biochemistry, 46, 4850-4860.  
17076634 G.L.Millhauser (2007).
Copper and the prion protein: methods, structures, function, and disease.
  Annu Rev Phys Chem, 58, 299-320.  
  21415934 G.Moro, L.Bonati, M.Bruschi, U.Cosentino, L.De Gioia, P.C.Fantucci, A.Pandini, E.Papaleo, D.Pitea, G.A.Saracino, and G.Zampella (2007).
Computational approaches to shed light on molecular mechanisms in biological processes.
  Theor Chem Acc, 117, 723-741.  
17686982 J.Dong, J.M.Canfield, A.K.Mehta, J.E.Shokes, B.Tian, W.S.Childers, J.A.Simmons, Z.Mao, R.A.Scott, K.Warncke, and D.G.Lynn (2007).
Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity.
  Proc Natl Acad Sci U S A, 104, 13313-13318.  
17616582 K.Kuwata, N.Nishida, T.Matsumoto, Y.O.Kamatari, J.Hosokawa-Muto, K.Kodama, H.K.Nakamura, K.Kimura, M.Kawasaki, Y.Takakura, S.Shirabe, J.Takata, Y.Kataoka, and S.Katamine (2007).
Hot spots in prion protein for pathogenic conversion.
  Proc Natl Acad Sci U S A, 104, 11921-11926.  
17292334 P.Tremblay, E.Bouzamondo-Bernstein, C.Heinrich, S.B.Prusiner, and S.J.DeArmond (2007).
Developmental expression of PrP in the post-implantation embryo.
  Brain Res, 1139, 60-67.  
16395451 A.P.Garnett, C.E.Jones, and J.H.Viles (2006).
A survey of diamagnetic probes for copper2+ binding to the prion protein. 1H NMR solution structure of the palladium2+ bound single octarepeat.
  Dalton Trans, (), 509-518.  
16912302 E.M.Norstrom, and J.A.Mastrianni (2006).
The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
  J Virol, 80, 8521-8529.  
17044782 J.K.Choi, S.J.Park, Y.C.Jun, J.M.Oh, B.H.Jeong, H.P.Lee, S.N.Park, R.I.Carp, and Y.S.Kim (2006).
Generation of monoclonal antibody recognized by the GXXXG motif (glycine zipper) of prion protein.
  Hybridoma (Larchmt), 25, 271-277.  
16519692 M.R.Hicks, A.C.Gill, I.K.Bath, A.K.Rullay, I.D.Sylvester, D.H.Crout, and T.J.Pinheiro (2006).
Synthesis and structural characterization of a mimetic membrane-anchored prion protein.
  FEBS J, 273, 1285-1299.  
16846506 N.Kachel, W.Kremer, R.Zahn, and H.R.Kalbitzer (2006).
Observation of intermediate states of the human prion protein by high pressure NMR spectroscopy.
  BMC Struct Biol, 6, 16.  
16911960 N.Piening, P.Weber, T.Högen, M.Beekes, H.Kretzschmar, and A.Giese (2006).
Photo-induced crosslinking of prion protein oligomers and prions.
  Amyloid, 13, 67-77.  
16751235 T.P.Knowles, and R.Zahn (2006).
Enhanced stability of human prion proteins with two disulfide bridges.
  Biophys J, 91, 1494-1500.  
15556981 A.Barducci, R.Chelli, P.Procacci, and V.Schettino (2005).
Misfolding pathways of the prion protein probed by molecular dynamics simulations.
  Biophys J, 88, 1334-1343.  
15647363 A.D.Gossert, S.Bonjour, D.A.Lysek, F.Fiorito, and K.Wüthrich (2005).
Prion protein NMR structures of elk and of mouse/elk hybrids.
  Proc Natl Acad Sci U S A, 102, 646-650.
PDB codes: 1xyw 1xyx 1y15 1y16
15647367 D.A.Lysek, C.Schorn, L.G.Nivon, V.Esteve-Moya, B.Christen, L.Calzolai, C.von Schroetter, F.Fiorito, T.Herrmann, P.Güntert, and K.Wüthrich (2005).
Prion protein NMR structures of cats, dogs, pigs, and sheep.
  Proc Natl Acad Sci U S A, 102, 640-645.
PDB codes: 1xyj 1xyk 1xyq 1xyu 1y2s
15772306 J.Torrent, M.T.Alvarez-Martinez, J.P.Liautard, C.Balny, and R.Lange (2005).
The role of the 132-160 region in prion protein conformational transitions.
  Protein Sci, 14, 956-967.  
15647366 L.Calzolai, D.A.Lysek, D.R.Pérez, P.Güntert, and K.Wüthrich (2005).
Prion protein NMR structures of chickens, turtles, and frogs.
  Proc Natl Acad Sci U S A, 102, 651-655.
PDB codes: 1u3m 1u5l 1xu0
16383425 Y.Y.Ji, Y.Q.Li, J.W.Mao, and X.W.Tang (2005).
Model study of prionlike folding behavior in aggregated proteins.
  Phys Rev E Stat Nonlin Soft Matter Phys, 72, 041912.  
15103636 A.Porrello, S.Soddu, J.P.Zbilut, M.Crescenzi, and A.Giuliani (2004).
Discrimination of single amino acid mutations of the p53 protein by means of deterministic singularities of recurrence quantification analysis.
  Proteins, 55, 743-755.  
15256076 C.Martinet-Edelist (2004).
Kinetic logic: a tool for describing the dynamics of infectious disease behavior.
  J Cell Mol Med, 8, 269-281.  
14991659 C.Renner, S.Fiori, F.Fiorino, D.Landgraf, D.Deluca, M.Mentler, K.Grantner, F.G.Parak, H.Kretzschmar, and L.Moroder (2004).
Micellar environments induce structuring of the N-terminal tail of the prion protein.
  Biopolymers, 73, 421-433.  
14983003 M.L.DeMarco, and V.Daggett (2004).
From conversion to aggregation: protofibril formation of the prion protein.
  Proc Natl Acad Sci U S A, 101, 2293-2298.  
15189155 P.Chien, J.S.Weissman, and A.H.DePace (2004).
Emerging principles of conformation-based prion inheritance.
  Annu Rev Biochem, 73, 617-656.  
15030571 S.Gilch, M.Nunziante, A.Ertmer, F.Wopfner, L.Laszlo, and H.M.Schätzl (2004).
Recognition of lumenal prion protein aggregates by post-ER quality control mechanisms is mediated by the preoctarepeat region of PrP.
  Traffic, 5, 300-313.  
12805563 C.J.Bosques, and B.Imperiali (2003).
The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment.
  Proc Natl Acad Sci U S A, 100, 7593-7598.  
12660996 J.Z.Chen, A.S.Lemak, J.R.Lepock, and J.P.Kemp (2003).
Minimal model for studying prion-like folding pathways.
  Proteins, 51, 283-288.  
14657385 K.Kuwata, T.Matumoto, H.Cheng, K.Nagayama, T.L.James, and H.Roder (2003).
NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106-126.
  Proc Natl Acad Sci U S A, 100, 14790-14795.  
12829502 K.S.Satheeshkumar, and R.Jayakumar (2003).
Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
  Biophys J, 85, 473-483.  
12849238 P.Montagna, P.Gambetti, P.Cortelli, and E.Lugaresi (2003).
Familial and sporadic fatal insomnia.
  Lancet Neurol, 2, 167-176.  
12897768 S.Lee, and D.Eisenberg (2003).
Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.
  Nat Struct Biol, 10, 725-730.  
12660994 S.Santini, J.B.Claude, S.Audic, and P.Derreumaux (2003).
Impact of the tail and mutations G131V and M129V on prion protein flexibility.
  Proteins, 51, 258-265.  
14622086 Y.Yao, J.Ren, and I.M.Jones (2003).
Amino terminal interaction in the prion protein identified using fusion to green fluorescent protein.
  J Neurochem, 87, 1057-1065.  
12011434 A.Grishaev, and M.Llinas (2002).
Protein structure elucidation from NMR proton densities.
  Proc Natl Acad Sci U S A, 99, 6713-6718.  
12496120 G.Settanni, T.X.Hoang, C.Micheletti, and A.Maritan (2002).
Folding pathways of prion and doppel.
  Biophys J, 83, 3533-3541.  
11891310 H.Wille, M.D.Michelitsch, V.Guenebaut, S.Supattapone, A.Serban, F.E.Cohen, D.A.Agard, and S.B.Prusiner (2002).
Structural studies of the scrapie prion protein by electron crystallography.
  Proc Natl Acad Sci U S A, 99, 3563-3568.  
12210822 M.D.Kirkitadze, G.Bitan, and D.B.Teplow (2002).
Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
  J Neurosci Res, 69, 567-577.  
11964260 N.Okimoto, K.Yamanaka, A.Suenaga, M.Hata, and T.Hoshino (2002).
Computational studies on prion proteins: effect of Ala(117)-->Val mutation.
  Biophys J, 82, 2746-2757.  
11916832 P.Tompa, G.E.Tusnády, P.Friedrich, and I.Simon (2002).
The role of dimerization in prion replication.
  Biophys J, 82, 1711-1718.  
12235358 P.Y.Chen, C.C.Lin, Y.T.Chang, S.C.Lin, and S.I.Chan (2002).
One O-linked sugar can affect the coil-to-beta structural transition of the prion peptide.
  Proc Natl Acad Sci U S A, 99, 12633-12638.  
12202354 R.I.Dima, and D.Thirumalai (2002).
Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
  Biophys J, 83, 1268-1280.  
11959975 U.Baxa, V.Speransky, A.C.Steven, and R.B.Wickner (2002).
Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein.
  Proc Natl Acad Sci U S A, 99, 5253-5260.  
11432744 B.Y.Lu, P.J.Beck, and J.Y.Chang (2001).
Oxidative folding of murine prion mPrP(23-231).
  Eur J Biochem, 268, 3767-3773.  
11157745 C.Wong, L.W.Xiong, M.Horiuchi, L.Raymond, K.Wehrly, B.Chesebro, and B.Caughey (2001).
Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
  EMBO J, 20, 377-386.  
11562491 D.D.Laws, H.M.Bitter, K.Liu, H.L.Ball, K.Kaneko, H.Wille, F.E.Cohen, S.B.Prusiner, A.Pines, and D.E.Wemmer (2001).
Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration.
  Proc Natl Acad Sci U S A, 98, 11686-11690.  
11248018 D.O.Alonso, S.J.DeArmond, F.E.Cohen, and V.Daggett (2001).
Mapping the early steps in the pH-induced conformational conversion of the prion protein.
  Proc Natl Acad Sci U S A, 98, 2985-2989.  
  11724914 G.S.Jackson, and J.Collinge (2001).
The molecular pathology of CJD: old and new variants.
  Mol Pathol, 54, 393-399.  
11892845 H.L.Ball, D.S.King, F.E.Cohen, S.B.Prusiner, and M.A.Baldwin (2001).
Engineering the prion protein using chemical synthesis.
  J Pept Res, 58, 357-374.  
11226243 H.Mo, R.C.Moore, F.E.Cohen, D.Westaway, S.B.Prusiner, P.E.Wright, and H.J.Dyson (2001).
Two different neurodegenerative diseases caused by proteins with similar structures.
  Proc Natl Acad Sci U S A, 98, 2352-2357.
PDB code: 1i17
11283320 J.Collinge (2001).
Prion diseases of humans and animals: their causes and molecular basis.
  Annu Rev Neurosci, 24, 519-550.  
11258885 J.H.Viles, D.Donne, G.Kroon, S.B.Prusiner, F.E.Cohen, H.J.Dyson, and P.E.Wright (2001).
Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics.
  Biochemistry, 40, 2743-2753.  
11404462 J.R.Requena, D.Groth, G.Legname, E.R.Stadtman, S.B.Prusiner, and R.L.Levine (2001).
Copper-catalyzed oxidation of the recombinant SHa(29-231) prion protein.
  Proc Natl Acad Sci U S A, 98, 7170-7175.  
11405232 K.Jansen, O.Schäfer, E.Birkmann, K.Post, H.Serban, S.B.Prusiner, and D.Riesner (2001).
Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
  Biol Chem, 382, 683-691.  
11509378 P.Derreumaux (2001).
Evidence that the 127-164 region of prion proteins has two equi-energetic conformations with beta or alpha features.
  Biophys J, 81, 1657-1665.  
11287647 P.Tompa, G.E.Tusnády, M.Cserzo, and I.Simon (2001).
Prion protein: evolution caught en route.
  Proc Natl Acad Sci U S A, 98, 4431-4436.  
11259607 S.Supattapone, E.Bouzamondo, H.L.Ball, H.Wille, H.O.Nguyen, F.E.Cohen, S.J.DeArmond, S.B.Prusiner, and M.Scott (2001).
A protease-resistant 61-residue prion peptide causes neurodegeneration in transgenic mice.
  Mol Cell Biol, 21, 2608-2616.  
11152514 S.Supattapone, T.Muramoto, G.Legname, I.Mehlhorn, F.E.Cohen, S.J.DeArmond, S.B.Prusiner, and M.R.Scott (2001).
Identification of two prion protein regions that modify scrapie incubation time.
  J Virol, 75, 1408-1413.  
11340627 Y.H.Abdulla (2001).
A plausible function of the prion protein: conjectures and a hypothesis.
  Bioessays, 23, 456-462.  
11746686 Y.Levy, E.Hanan, B.Solomon, and O.M.Becker (2001).
Helix-coil transition of PrP106-126: molecular dynamic study.
  Proteins, 45, 382-396.  
11391773 Y.Matsunaga, D.Peretz, A.Williamson, D.Burton, I.Mehlhorn, D.Groth, F.E.Cohen, S.B.Prusiner, and M.A.Baldwin (2001).
Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH.
  Proteins, 44, 110-118.  
10951327 C.Guilbert, F.Ricard, and J.C.Smith (2000).
Dynamic simulation of the mouse prion protein.
  Biopolymers, 54, 406-415.  
11080207 D.L.Rymer, and T.A.Good (2000).
The role of prion peptide structure and aggregation in toxicity and membrane binding.
  J Neurochem, 75, 2536-2545.  
11076515 E.Aronoff-Spencer, C.S.Burns, N.I.Avdievich, G.J.Gerfen, J.Peisach, W.E.Antholine, H.L.Ball, F.E.Cohen, S.B.Prusiner, and G.L.Millhauser (2000).
Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy.
  Biochemistry, 39, 13760-13771.  
10899999 F.López Garcia, R.Zahn, R.Riek, and K.Wüthrich (2000).
NMR structure of the bovine prion protein.
  Proc Natl Acad Sci U S A, 97, 8334-8339.
PDB codes: 1dwy 1dwz 1dx0 1dx1
10679460 G.S.Jackson, and A.R.Clarke (2000).
Mammalian prion proteins.
  Curr Opin Struct Biol, 10, 69-74.  
10704232 I.V.Baskakov, C.Aagaard, I.Mehlhorn, H.Wille, D.Groth, M.A.Baldwin, S.B.Prusiner, and F.E.Cohen (2000).
Self-assembly of recombinant prion protein of 106 residues.
  Biochemistry, 39, 2792-2804.  
10900000 L.Calzolai, D.A.Lysek, P.Guntert, C.von Schroetter, R.Riek, R.Zahn, and K.Wüthrich (2000).
NMR structures of three single-residue variants of the human prion protein.
  Proc Natl Acad Sci U S A, 97, 8340-8345.
PDB codes: 1e1g 1e1j 1e1p 1e1s 1e1u 1e1w
10756050 L.Zulianello, K.Kaneko, M.Scott, S.Erpel, D.Han, F.E.Cohen, and S.B.Prusiner (2000).
Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.
  J Virol, 74, 4351-4360.  
  11087170 M.Haltia (2000).
Human prion diseases.
  Ann Med, 32, 493-500.  
10713992 O.G.Parchment, and J.W.Essex (2000).
Molecular dynamics of mouse and Syrian hamster PrP: implications for activity.
  Proteins, 38, 327-340.  
  10752620 O.V.Galzitskaya, A.K.Surin, and H.Nakamura (2000).
Optimal region of average side-chain entropy for fast protein folding.
  Protein Sci, 9, 580-586.  
  10716185 R.M.Whittal, H.L.Ball, F.E.Cohen, A.L.Burlingame, S.B.Prusiner, and M.A.Baldwin (2000).
Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry.
  Protein Sci, 9, 332-343.  
10618385 R.Zahn, A.Liu, T.Lührs, R.Riek, C.von Schroetter, F.López García, M.Billeter, L.Calzolai, G.Wider, and K.Wüthrich (2000).
NMR solution structure of the human prion protein.
  Proc Natl Acad Sci U S A, 97, 145-150.
PDB codes: 1qlx 1qlz 1qm0 1qm1 1qm2 1qm3
10823951 V.Perrier, A.C.Wallace, K.Kaneko, J.Safar, S.B.Prusiner, and F.E.Cohen (2000).
Mimicking dominant negative inhibition of prion replication through structure-based drug design.
  Proc Natl Acad Sci U S A, 97, 6073-6078.  
10966577 X.Zhou, F.Alber, G.Folkers, G.H.Gonnet, and G.Chelvanayagam (2000).
An analysis of the helix-to-strand transition between peptides with identical sequence.
  Proteins, 41, 248-256.  
10583417 E.Ragg, F.Tagliavini, P.Malesani, L.Monticelli, O.Bugiani, G.Forloni, and M.Salmona (1999).
Determination of solution conformations of PrP106-126, a neurotoxic fragment of prion protein, by 1H NMR and restrained molecular dynamics.
  Eur J Biochem, 266, 1192-1201.  
10209273 G.S.Jackson, A.F.Hill, C.Joseph, L.Hosszu, A.Power, J.P.Waltho, A.R.Clarke, and J.Collinge (1999).
Multiple folding pathways for heterologously expressed human prion protein.
  Biochim Biophys Acta, 1431, 1.  
10220323 H.Liu, S.Farr-Jones, N.B.Ulyanov, M.Llinas, S.Marqusee, D.Groth, F.E.Cohen, S.B.Prusiner, and T.L.James (1999).
Solution structure of Syrian hamster prion protein rPrP(90-231).
  Biochemistry, 38, 5362-5377.  
10051591 J.H.Viles, F.E.Cohen, S.B.Prusiner, D.B.Goodin, P.E.Wright, and H.J.Dyson (1999).
Copper binding to the prion protein: structural implications of four identical cooperative binding sites.
  Proc Natl Acad Sci U S A, 96, 2042-2047.  
10501201 M.F.Jobling, L.R.Stewart, A.R.White, C.McLean, A.Friedhuber, F.Maher, K.Beyreuther, C.L.Masters, C.J.Barrow, S.J.Collins, and R.Cappai (1999).
The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126.
  J Neurochem, 73, 1557-1565.  
10369660 M.Horiuchi, and B.Caughey (1999).
Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
  EMBO J, 18, 3193-3203.  
10500170 M.P.Morrissey, and E.I.Shakhnovich (1999).
Evidence for the role of PrP(C) helix 1 in the hydrophilic seeding of prion aggregates.
  Proc Natl Acad Sci U S A, 96, 11293-11298.  
  10493576 M.Young, K.Kirshenbaum, K.A.Dill, and S.Highsmith (1999).
Predicting conformational switches in proteins.
  Protein Sci, 8, 1752-1764.  
10557270 P.M.Rudd, T.Endo, C.Colominas, D.Groth, S.F.Wheeler, D.J.Harvey, M.R.Wormald, H.Serban, S.B.Prusiner, A.Kobata, and R.A.Dwek (1999).
Glycosylation differences between the normal and pathogenic prion protein isoforms.
  Proc Natl Acad Sci U S A, 96, 13044-13049.  
10079070 R.Cappai, L.Stewart, M.F.Jobling, J.M.Thyer, A.R.White, K.Beyreuther, S.J.Collins, C.L.Masters, and C.J.Barrow (1999).
Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
  Biochemistry, 38, 3280-3284.  
  10611945 S.Benvenga, A.Campenni, and A.Facchiano (1999).
Internal repeats of prion protein and A beta PP, and reciprocal similarity with the amyloid-related proteins.
  Amyloid, 6, 250-255.  
10079068 S.Liemann, and R.Glockshuber (1999).
Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
  Biochemistry, 38, 3258-3267.  
10102274 S.Supattapone, P.Bosque, T.Muramoto, H.Wille, C.Aagaard, D.Peretz, H.O.Nguyen, C.Heinrich, M.Torchia, J.Safar, F.E.Cohen, S.J.DeArmond, S.B.Prusiner, and M.Scott (1999).
Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice.
  Cell, 96, 869-878.  
  9811348 A.Jiménez-Huete, P.M.Lievens, R.Vidal, P.Piccardo, B.Ghetti, F.Tagliavini, B.Frangione, and F.Prelli (1998).
Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues.
  Am J Pathol, 153, 1561-1572.  
9613198 D.Doyle, and M.Rogers (1998).
A new mechanism broadening the role of prion proteins in neurodegeneration.
  Trends Genet, 14, 171-173.  
9736680 D.Westaway, G.Telling, and S.Priola (1998).
Prions.
  Proc Natl Acad Sci U S A, 95, 11030-11031.  
9759504 F.E.Cohen, and S.B.Prusiner (1998).
Pathologic conformations of prion proteins.
  Annu Rev Biochem, 67, 793-819.  
9771749 J.Safar, H.Wille, V.Itri, D.Groth, H.Serban, M.Torchia, F.E.Cohen, and S.B.Prusiner (1998).
Eight prion strains have PrP(Sc) molecules with different conformations.
  Nat Med, 4, 1157-1165.  
9448261 J.W.Kelly (1998).
The environmental dependency of protein folding best explains prion and amyloid diseases.
  Proc Natl Acad Sci U S A, 95, 930-932.  
  9765500 R.A.Williamson, D.Peretz, C.Pinilla, H.Ball, R.B.Bastidas, R.Rozenshteyn, R.A.Houghten, S.B.Prusiner, and D.R.Burton (1998).
Mapping the prion protein using recombinant antibodies.
  J Virol, 72, 9413-9418.  
9644969 R.C.Prince, and D.E.Gunson (1998).
Prions are copper-binding proteins.
  Trends Biochem Sci, 23, 197-198.  
9751723 R.Riek, G.Wider, M.Billeter, S.Hornemann, R.Glockshuber, and K.Wüthrich (1998).
Prion protein NMR structure and familial human spongiform encephalopathies.
  Proc Natl Acad Sci U S A, 95, 11667-11672.  
9811807 S.B.Prusiner (1998).
Prions.
  Proc Natl Acad Sci U S A, 95, 13363-13383.  
9590169 S.B.Prusiner, M.R.Scott, S.J.DeArmond, and F.E.Cohen (1998).
Prion protein biology.
  Cell, 93, 337-348.  
9742683 S.G.Jacchieri (1998).
Study of alpha-helix to beta-strand to beta-sheet transitions in amyloid: the role of segregated hydrophobic beta-strands.
  Biophys Chem, 74, 23-34.  
9720262 V.Daggett (1998).
Structure-function aspects of prion proteins.
  Curr Opin Biotechnol, 9, 359-365.  
9391046 D.G.Donne, J.H.Viles, D.Groth, I.Mehlhorn, T.L.James, F.E.Cohen, S.B.Prusiner, P.E.Wright, and H.J.Dyson (1997).
Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.
  Proc Natl Acad Sci U S A, 94, 13452-13457.  
9405603 M.R.Scott, J.Safar, G.Telling, O.Nguyen, D.Groth, M.Torchia, R.Koehler, P.Tremblay, D.Walther, F.E.Cohen, S.J.DeArmond, and S.B.Prusiner (1997).
Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice.
  Proc Natl Acad Sci U S A, 94, 14279-14284.  
9427256 S.J.DeArmond, H.Sánchez, F.Yehiely, Y.Qiu, A.Ninchak-Casey, V.Daggett, A.P.Camerino, J.Cayetano, M.Rogers, D.Groth, M.Torchia, P.Tremblay, M.R.Scott, F.E.Cohen, and S.B.Prusiner (1997).
Selective neuronal targeting in prion disease.
  Neuron, 19, 1337-1348.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer